PILMAN » scrutiny http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 Pharma Innovation Absolutely Critical: But NOT Shorn from Ethics, Propriety, Compliance and Values http://www.tapanray.in/pharma-innovation-absolutely-critical-but-not-shorn-from-ethics-propriety-compliance-and-values/?utm_source=rss&utm_medium=rss&utm_campaign=pharma-innovation-absolutely-critical-but-not-shorn-from-ethics-propriety-compliance-and-values http://www.tapanray.in/pharma-innovation-absolutely-critical-but-not-shorn-from-ethics-propriety-compliance-and-values/#comments Mon, 20 May 2013 00:00:08 +0000 Tapan Ray http://www.tapanray.in/?p=2481 Continue reading →]]> http://www.tapanray.in/pharma-innovation-absolutely-critical-but-not-shorn-from-ethics-propriety-compliance-and-values/feed/ 0 ‘Havoc’ and its ‘Aftermath’: Clinical Trials in India http://www.tapanray.in/havoc-and-its-aftermath-clinical-trials-in-india/?utm_source=rss&utm_medium=rss&utm_campaign=havoc-and-its-aftermath-clinical-trials-in-india http://www.tapanray.in/havoc-and-its-aftermath-clinical-trials-in-india/#comments Mon, 14 Jan 2013 00:00:56 +0000 Tapan Ray http://www.tapanray.in/?p=1427 Continue reading →]]> http://www.tapanray.in/havoc-and-its-aftermath-clinical-trials-in-india/feed/ 0 Will the ‘Bayer–Cipla case’ now put the ‘Bolar Provision’ under judicial scrutiny? http://www.tapanray.in/will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny/?utm_source=rss&utm_medium=rss&utm_campaign=will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny http://www.tapanray.in/will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny/#comments Thu, 22 Oct 2009 01:00:17 +0000 Tapan Ray http://tapanray.in/index.php/?p=748 Continue reading →]]> http://www.tapanray.in/will-the-bayer-cipla-case-now-put-the-bolar-provision-under-judicial-scrutiny/feed/ 0